Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcatheter Aortic Valve Replacement | 45 | 2024 | 197 | 12.500 |
Why?
|
| Aortic Valve Stenosis | 38 | 2024 | 332 | 10.240 |
Why?
|
| Heart Valve Prosthesis | 38 | 2024 | 293 | 8.570 |
Why?
|
| Mitral Valve Insufficiency | 18 | 2024 | 156 | 5.510 |
Why?
|
| Heart Valve Prosthesis Implantation | 22 | 2024 | 429 | 5.470 |
Why?
|
| Aortic Valve | 38 | 2024 | 437 | 4.170 |
Why?
|
| Mitral Valve | 15 | 2024 | 245 | 1.990 |
Why?
|
| Prosthesis Design | 22 | 2024 | 672 | 1.710 |
Why?
|
| Treatment Outcome | 57 | 2024 | 12115 | 1.660 |
Why?
|
| Aortic Valve Insufficiency | 5 | 2024 | 140 | 1.400 |
Why?
|
| Bundle-Branch Block | 2 | 2020 | 35 | 1.330 |
Why?
|
| Cardiac Catheterization | 15 | 2024 | 631 | 1.330 |
Why?
|
| Bioprosthesis | 3 | 2024 | 111 | 1.060 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2024 | 63 | 0.990 |
Why?
|
| Aged, 80 and over | 26 | 2024 | 6374 | 0.920 |
Why?
|
| Risk Factors | 32 | 2024 | 10018 | 0.850 |
Why?
|
| Postoperative Complications | 14 | 2024 | 3011 | 0.830 |
Why?
|
| Predictive Value of Tests | 10 | 2024 | 2112 | 0.800 |
Why?
|
| Hemodynamics | 8 | 2024 | 844 | 0.740 |
Why?
|
| Registries | 10 | 2024 | 1394 | 0.700 |
Why?
|
| Ventricular Septum | 1 | 2020 | 16 | 0.680 |
Why?
|
| Humans | 71 | 2024 | 123103 | 0.650 |
Why?
|
| Multidetector Computed Tomography | 6 | 2020 | 35 | 0.630 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2024 | 233 | 0.590 |
Why?
|
| Aged | 26 | 2024 | 19093 | 0.580 |
Why?
|
| Heart Ventricles | 1 | 2020 | 762 | 0.490 |
Why?
|
| Acute Coronary Syndrome | 3 | 2024 | 203 | 0.490 |
Why?
|
| Retrospective Studies | 23 | 2024 | 16044 | 0.450 |
Why?
|
| Catheters | 2 | 2024 | 89 | 0.420 |
Why?
|
| Heart Valve Diseases | 3 | 2023 | 166 | 0.400 |
Why?
|
| Prosthesis-Related Infections | 2 | 2024 | 176 | 0.390 |
Why?
|
| Calcinosis | 2 | 2023 | 170 | 0.360 |
Why?
|
| Balloon Valvuloplasty | 2 | 2021 | 25 | 0.360 |
Why?
|
| Echocardiography | 5 | 2024 | 1049 | 0.360 |
Why?
|
| Frailty | 2 | 2023 | 98 | 0.340 |
Why?
|
| Risk Assessment | 7 | 2024 | 3325 | 0.330 |
Why?
|
| Heart Failure | 4 | 2024 | 2128 | 0.330 |
Why?
|
| Severity of Illness Index | 6 | 2024 | 2847 | 0.310 |
Why?
|
| Feasibility Studies | 4 | 2024 | 756 | 0.310 |
Why?
|
| Prosthesis Failure | 3 | 2024 | 159 | 0.300 |
Why?
|
| Reoperation | 4 | 2024 | 818 | 0.290 |
Why?
|
| Coronary Artery Disease | 2 | 2024 | 748 | 0.290 |
Why?
|
| Endocarditis | 2 | 2024 | 101 | 0.270 |
Why?
|
| Male | 23 | 2024 | 60129 | 0.260 |
Why?
|
| Coronary Vessels | 2 | 2020 | 526 | 0.250 |
Why?
|
| Device Removal | 2 | 2024 | 222 | 0.250 |
Why?
|
| Middle Aged | 10 | 2024 | 25992 | 0.250 |
Why?
|
| Time Factors | 10 | 2024 | 6219 | 0.240 |
Why?
|
| Clinical Decision-Making | 3 | 2024 | 265 | 0.230 |
Why?
|
| Atrial Pressure | 1 | 2024 | 6 | 0.230 |
Why?
|
| Atrial Function, Left | 1 | 2024 | 27 | 0.230 |
Why?
|
| Female | 21 | 2024 | 65514 | 0.230 |
Why?
|
| Mercury | 1 | 2024 | 27 | 0.230 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2024 | 52 | 0.220 |
Why?
|
| Heart Valves | 1 | 2024 | 51 | 0.220 |
Why?
|
| Propensity Score | 1 | 2024 | 211 | 0.210 |
Why?
|
| Pulmonary Veins | 1 | 2024 | 161 | 0.200 |
Why?
|
| Shock, Cardiogenic | 2 | 2021 | 187 | 0.200 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 196 | 0.200 |
Why?
|
| Tricuspid Valve | 1 | 2022 | 59 | 0.200 |
Why?
|
| Aortography | 2 | 2019 | 200 | 0.190 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2022 | 45 | 0.190 |
Why?
|
| Databases, Factual | 2 | 2024 | 1172 | 0.190 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 25 | 0.190 |
Why?
|
| Recovery of Function | 4 | 2024 | 437 | 0.170 |
Why?
|
| Patient Readmission | 2 | 2021 | 368 | 0.170 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2020 | 14 | 0.170 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2019 | 4 | 0.170 |
Why?
|
| Health Resources | 1 | 2020 | 115 | 0.160 |
Why?
|
| Organ Size | 1 | 2020 | 412 | 0.160 |
Why?
|
| Outpatients | 1 | 2020 | 254 | 0.160 |
Why?
|
| Myocarditis | 1 | 2019 | 119 | 0.150 |
Why?
|
| Hemodynamic Monitoring | 1 | 2018 | 12 | 0.150 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 107 | 0.150 |
Why?
|
| Radiography, Interventional | 1 | 2018 | 87 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 197 | 0.150 |
Why?
|
| Coronary Angiography | 1 | 2019 | 420 | 0.140 |
Why?
|
| Survival Rate | 4 | 2023 | 1999 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 489 | 0.130 |
Why?
|
| Incidence | 1 | 2022 | 3039 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 630 | 0.120 |
Why?
|
| Pilot Projects | 4 | 2020 | 1389 | 0.120 |
Why?
|
| Heart-Assist Devices | 1 | 2023 | 1026 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1001 | 0.110 |
Why?
|
| Hospital Mortality | 3 | 2021 | 1010 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 5039 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1660 | 0.090 |
Why?
|
| North America | 2 | 2020 | 239 | 0.080 |
Why?
|
| Fluoroscopy | 2 | 2020 | 91 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1071 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 2055 | 0.060 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2024 | 21 | 0.060 |
Why?
|
| United States | 4 | 2021 | 10651 | 0.060 |
Why?
|
| Systole | 1 | 2024 | 196 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 121 | 0.060 |
Why?
|
| Workflow | 1 | 2024 | 114 | 0.060 |
Why?
|
| Health Facilities | 1 | 2024 | 58 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4512 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2024 | 129 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2024 | 449 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2024 | 220 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2024 | 229 | 0.050 |
Why?
|
| Thinness | 1 | 2023 | 68 | 0.050 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2022 | 22 | 0.050 |
Why?
|
| Tachycardia, Ventricular | 1 | 2023 | 197 | 0.050 |
Why?
|
| Dilatation | 1 | 2021 | 68 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 607 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2023 | 445 | 0.050 |
Why?
|
| Steroids | 1 | 2022 | 201 | 0.040 |
Why?
|
| Dobutamine | 1 | 2020 | 55 | 0.040 |
Why?
|
| Milrinone | 1 | 2020 | 30 | 0.040 |
Why?
|
| Radial Artery | 1 | 2020 | 26 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 439 | 0.040 |
Why?
|
| Health Status | 1 | 2022 | 374 | 0.040 |
Why?
|
| New York | 1 | 2020 | 68 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 459 | 0.040 |
Why?
|
| Overweight | 1 | 2023 | 358 | 0.040 |
Why?
|
| Endocardium | 1 | 2019 | 50 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 258 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2024 | 482 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 57 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 496 | 0.040 |
Why?
|
| Europe | 1 | 2020 | 350 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2020 | 190 | 0.040 |
Why?
|
| Cardiotonic Agents | 1 | 2020 | 135 | 0.040 |
Why?
|
| Cardiac Catheters | 1 | 2018 | 8 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2021 | 381 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2018 | 56 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 353 | 0.040 |
Why?
|
| Pneumonectomy | 1 | 2019 | 129 | 0.040 |
Why?
|
| Troponin T | 1 | 2019 | 245 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 424 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 2799 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 238 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 1176 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2023 | 1548 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1236 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 723 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 986 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2019 | 957 | 0.030 |
Why?
|
| Stents | 1 | 2020 | 877 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 2393 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 1739 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2230 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4699 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1593 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3545 | 0.020 |
Why?
|